Related Experiment Videos
Multiple stem cell traits of expanded rat bone marrow stromal cells.
Jung Yeon Lim1, Sin-Soo Jeun, Kyung-Jin Lee
1Department of Neurosurgery, The Catholic University of Korea, Seoul 137-701, Republic of Korea.
Experimental Neurology
|April 29, 2006
Summary
Early passage bone marrow stromal cells (BMSC) show superior stem cell traits compared to later passages. These findings highlight the importance of BMSC expansion time for cell therapy and in vitro applications.
Area of Science:
- Cell Biology
- Stem Cell Research
- Tissue Engineering
Background:
- Bone marrow stromal cells (BMSC) possess stem cell characteristics, including self-renewal, proliferation, and differentiation.
- The impact of cell expansion time on BMSC stemness remains an area of investigation.
Purpose of the Study:
- To compare the stem cell potential of early (2nd passage) and late (10th passage) cultured BMSC.
- To evaluate differences in morphology, proliferation, apoptosis, and multi-lineage differentiation capacity.
Main Methods:
- Cultured BMSC at 2nd and 10th passages were analyzed.
- Morphological characteristics and BMSC-related antigen expression (CD90, CD73) were assessed.
- Cell proliferative capacity and apoptosis rates were measured.
- Differentiation potential into mesodermal (osteocytes, adipocytes) and ectodermal (neurons) lineages was evaluated.
Main Results:
- 10th passage BMSC displayed altered morphology and reduced expression of BMSC-related antigens compared to 2nd passage cells.
- 2nd passage BMSC exhibited approximately double the proliferative capacity and lower apoptosis rates than 10th passage BMSC.
- Early passage BMSC demonstrated more effective differentiation into osteocytes, adipocytes, and neurons.
Conclusions:
- BMSC stem cell potential, including proliferation and differentiation, diminishes with increased passage number.
- Early passage BMSC are a more suitable cell source for in vitro applications and cell therapy.
- Expansion time is a critical factor influencing BMSC characteristics and therapeutic utility.